Skip to content

Opening book details…

About this Medicine article

Activity of Temsirolimus Added to Cetuximab in Patients With Cetuximab-Resistant, Recurrent/Metastatic Head-and-Neck Cancer: Results of the Randomized Phase 2 Maestro-HN Study by Seiwert, T.Y.; Adkins, D.; Worden, F.; Wade, J.L.; Hu, S.; Price, K.; Zavala, J.; Lussier, Y.; Vokes, E.E.; Cohen, E.E.W. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Seiwert, T.Y.; Adkins, D.; Worden, F.; Wade, J.L.; Hu, S.; Price, K.; Zavala, J.; Lussier, Y.; Vokes, E.E.; Cohen, E.E.W.
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0360-3016)
Published
2014
Language
EN
Field
Medicine (Health Sciences)

More by Seiwert, T.Y.; Adkins, D.; Worden, F.; Wade, J.L.; Hu, S.; Price, K.; Zavala, J.; Lussier, Y.; Vokes, E.E.; Cohen, E.E.W.

Browse all works by Seiwert, T.Y.; Adkins, D.; Worden, F.; Wade, J.L.; Hu, S.; Price, K.; Zavala, J.; Lussier, Y.; Vokes, E.E.; Cohen, E.E.W.